Discover our latest blogs

For many European medical device companies, the US represents the next growth market. The surprise comes when they discover thata CE mark, established quality...

Your medical device's AI algorithm will not stay the same after it reaches the market. It will be retrained, refined, and improved, and every one of those...

The conversation everyone is having Over the past months, I have found myself having the same conversation again and again. Customers are experimenting with...

Power Platform governance used to be a fairly clear conversation.

Artificial intelligence is no longer a future technology for pharma; it is already part of the infrastructure that supports scientific progress, operational...

Pharma is in the middle of its biggest regulatory shift in more than 30 years. And for the first time, regulators are directly addressing AI, with its own...

The business wants AI agents, the use cases look compelling, and the technology is moving faster than anyone can comfortably track, and then somewhere in the...

Most pharma AI initiatives do not fail because the technology does not work. They fail because no one can clearly answer a much more basic question: Who owns...

Imagine intelligent digital colleagues that work proactively and learn from user feedback; designed to automate repetitive tasks, reduce errors and give your...